Top 10 Medical Stocks To Buy Right Now


With Social Security funding issues around the corner, uncertain market conditions, long-term low interest rates and skyrocketing medical costs, American retirees are facing a laundry list of retirement challenges. The only certainty is that retirement is going to be dramatically different than the retirement previous generations encountered. In order to retire with financial security and dignity, Americans need to make well-informed decisions about when to retire, when to collect Social Security, how to manage their retirement savings and what to do about housing in retirement.  It is this last item, housing in retirement, which often gets the least amount of attention, when in fact, it should be closely scrutinized as a powerful asset.


New research from The American College of Financial Services, The Home Equity and Retirement Income Planning Survey, found that the overwhelming majority, 83 percent of Americans nearing or in retirement, want to remain in their current home for as long as possible. Additionally, the desire to remain in one’s home increased with age. Perhaps somewhat surprisingly, not only did the desire to remain in one’s home increase with age, but the number of years the respondent expected to remain in the home also increased with age. Even if the homeowner needed to relocate later in retirement, almost none of the respondents expressed a desire to rent. This research has also been published in the Journal of Financial Planning – see here.

Top 10 Medical Stocks To Buy Right Now: Catalyst Biosciences, Inc. (CBIO)


Advisors’ Opinion:

  • [By Ashley Moore]

    Here is a list of the top 10 best small-cap stocks based on price gains per share so far in 2017:

    Company (Ticker)Price per Share% Change AquaBounty Technologies Inc. (Nasdaq: AQB)$14.338,646.99%Rennova Health Inc. (Nasdaq: RNVA)$3.133,333.73%China Gengsheng Minerals Inc. (OTCMKTS: CHGS)$0.021,718.18%Sunshine Heart Inc. (Nasdaq: SSH)$3.851,071.43%CTI BioPharma Corp. (Nasdaq: CTIC)$4.30991.76%Catalyst Biosciences Inc. (Nasdaq: CBIO)$6.22853.85%TearLab Corp. (Nasdaq: TEAR)$4.20707.85%Pulmatrix Inc. (Nasdaq: PULM)$3.86566.10%Real Goods Solar Inc. (Nasdaq: RGSE)$1.43498.75%Calithera Biosciences Inc. (Nasdaq: CALA)$11.70281.54%

  • [By Lisa Levin]

    Gainers

    Pyxis Tankers Inc. (NYSE: PXS) rose 47.48 percent to $$5.56, after the company announced it has entered into a definitive securities purchase agreement with a group of investors, which will result in gross proceeds of $4.8 million.
    Sigma Designs Inc (NASDAQ: SIGM) rose 22.77 percent to $6.88. Silicon Laboratories (NASDAQ: SLAB) announced plans to buy Sigma Designs for $7.05 per share in cash.
    Steadymed Ltd (NASDAQ: STDY) rose 19.35 percent to $3.70, after the company reported that no clinical trials were required for Trevyent and that the FDA had agreed to the pathway for the drug candidate's NDA resubmission.
    Iteris, Inc. (NASDAQ: ITI) rose 15.73 percent to $7.06. Earlier in the week, Zacks Investment Research had upgraded the company from "Sell" to "Hold".
    Science Applications International Corp (NYSE: SAIC) rose 13.71 percent to $85.77 as the company reported better-than-expected earnings for its third quarter.
    Technical Communications Corporation (NASDAQ: TCCO) rose 12.41 percent to $6.07, after having risen sharply in pre-marketing trading.
    Radius Health, Inc. (NASDAQ: RDUS) rose 12.41 percent to $30.81 after the company provided an update on data from the Phase 1 005 clinical study of elacestrant in patients with estrogen receptor positive breast cancer during the 2017 San Antonio Breast Cancer Symposium.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 12.32 percent to $25.80 after the company reported its third quarter financial results.
    Prana Biotechnology Limited (NASDAQ: PRAN) rose 11.36 percent to $3.43, as the company announced a research collaboration with Takeda Pharmaceuticals to study the ability of movement disorders compound, PBT434 to slow or prevent neurodegeneration of the gastrointestinal system.
    Catalyst Biosciences, Inc. (NASDAQ: CBIO) rose 10.49 percent to $7.90 as the company announced the appointment of Arwa Shurrab and Jamie Ellen Siegel in its clinical hemophilia

  • [By Lisa Levin]

    Shares of Catalyst Biosciences Inc (NASDAQ: CBIO) were down around 27 percent to $5.36. Catalyst Biosciences reported the pricing of $18 million offering of Class A units at $5 per unit

Top 10 Medical Stocks To Buy Right Now: Alexion Pharmaceuticals, Inc.(ALXN)

Advisors’ Opinion:

  • [By Paul Ausick]

    Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) posted a new 52-week low of $102.47 on Tuesday, down more than 11% compared with Monday’s closing price of $115.42. The stock’s 52-week high is $157.02. Volume totaled more than 16 million shares, nearly 6 times the daily average of about 3 million. The company announced several executive changes this morning.

  • [By Lisa Levin] Related Chardan Analyst Suggests An AveXis-Ionis Pair Trade Why The Biogen-Ionis News Is A Boon For AveXis AveXis' (AVXS) CEO Sean Nolan on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related CLBS Earnings Scheduled For March 17, 2017 15 Biggest Mid-Day Gainers For Thursday Caladrius Biosciences beats by $0.07, beats on revenue (Seeking Alpha) Gainers
    Caladrius Biosciences Inc (NASDAQ: CLBS) shares rose 20.2 percent to $6.13 in pre-market trading after the company reported a narrower-than-expected quarterly loss.
    Arbutus Biopharma Corp (NASDAQ: ABUS) rose 12.3 percent to $3.20 in pre-market trading after the company disclosed that it has licensed LNP delivery technology to Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) for use in single messenger RNA product candidate.
    AveXis Inc (NASDAQ: AVXS) rose 12.2 percent to $81.66 in pre-market trading after the company reported topline data from Phase 1 trial of AVXS-101.
    TOP SHIPS Inc (NASDAQ: TOPS) shares rose 10.5 percent to $2.43 in pre-market trading after surging 109.52 percent on Thursday.
    ChipMOS TECHNOLOGIES INC. (NASDAQ: IMOS) rose 9.8 percent to $17.45 in pre-market trading after declining 0.44 percent on Thursday.
    Sino-Global Shipping America, Ltd. (NASDAQ: SINO) rose 8.3 percent to $3.38 in pre-market trading after climbing 23.81 percent on Thursday.
    Diana Containerships Inc (NASDAQ: DCIX) rose 7.6 percent to $2.99 in pre-market trading after surging 12.55 percent on Thursday.
    Steel Dynamics, Inc. (NASDAQ: STLD) rose 5.2 percent to $37.25 in pre-market trading. Steel Dynamics expects Q1 earnings of $0.77 to $0.81 per diluted share. The company also declared a quarterly cash dividend of $0.1550 per common share.
    Adobe Systems Incorporated (NASDAQ: ADBE)
  • [By Ben Levisohn]

    Alexion Pharmaceuticals (ALXN) tumbled to the bottom of the S&P 500 today after the company’s CEO and CFO left the firm following the delay of its 10-Q last month.

    Getty Images

    Alexion Pharmaceuticals dropped 13% to $115.04 today, while the S&P 500 dipped 0.1% to 2,256.96.

    BMO’s M. Ian Somaiya offers his take on the chaos at Alexion:

    Alexion has delayed its 3Q 10-Q filing as a result of an internal investigation involving the company’s sales practices. The company continues to believe restatement of previously reported results is not required.Alexion expects filing of 3Q 10-Q in January 2017 or earlier, and 4Q/FY2016 earnings in February, when guidance is expected.


    Near-term downside may be priced in, caution on guidance. We believe the announcement of new management adds a new overhang to the stock, but also believe downside may be priced in (Alexion is down ~9% at open) and may provide an opportunity for investors to dip their toes if not their feet. We believe Alexion’s recovery will be driven by its next-generation C5 inhibitor, ALXN-1210, as every-eight-week dosing should enable Alexion to maintain 75% of the PNH market, while SubQ success, depending on dosing schedule/volume, may enable Alexion to do better. Additionally, we believe label extensions for Soliris in rMG, NMO may provide near-term growth drivers. Further upside is dependent on 30 pre-clinical assets in Alexion’s pipeline and the pace of Soliris adoption in MG. We believe the weakness may provide a unique opportunity for accumulation, with potential downside risk related to guidance from new management during 4Q/FY2016 earnings in February.


    Alexion Pharmaceuticals’ market capitalization fell to $25.8 billion today from $29.6 billion yesterday. It reported net income of $144 million on sales of $2.5 billion in 2015.

  • [By David Sterman]

    Growth-oriented investors should also check out Alexion Pharmaceuticals (Nasdaq: ALXN(link is external)), which falls through the cracks between the massive well-established biotechs, and the small-cap biotechs that are still pre-revenue.

    Alexion targets rare and severe diseases, and has built a broad platform of drugs to treat them. Sales growth has never been less than 37% at any point in the past eight years, and 20% to 25% growth appears locked in over coming years as well. Analysts at UBS, who see 30% upside to their $202 price target, believe that a healthy drug pipeline provides multiple catalysts this year in the form of clinical trial updates. They suggest that shares would be worth $230 in a buyout scenario. 

  • [By Ben Levisohn]

    Alexion Pharmaceuticals (ALXN) soared to the top of the S&P 500 today after its audit committee found no need to restate the company’s financials.

    Agence France-Presse/Getty Images

    Alexion Pharmaceuticalsgained 9.5% to $139.18 today, while the S&P 500 dipped 0.1% to 2,269.00.

    Morgan Stanley’sMatthew Harrison and team argue that the audit committees report is “lifting a cloud” over Alexion, but they still have their concerns:

    Without significant fireworks mgt. has filed the 10-Q lifting a cloud around the details on the potential wrong doing and its impact. While the “pull-in” sales had less than a 1% impact and do not appear pervasive in use as evidenced by the limited amount outside of 4Q15, we do wonder how the increased scrutiny will impact the selling organization and the potential increased conservatism among personnel going forward. We look forward to 2017 guidance and updates to MG filing and 1210 enrollment at the 4Q16 call.


    Alexion’s market capitalization rose to $31.2 billion today from $28.5 billion yesterday. It reported net income of $144 million on sales of $2.5 billion in 2015.

Top 10 Medical Stocks To Buy Right Now: Fortinet, Inc.(FTNT)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Palo Alto Networks outperforming (albeit off previous highs)potential peers in the space such as large cap Cisco Systems, Inc (NASDAQ: CSCO), mid capFortinet Inc (NASDAQ: FTNT) and small cap Barracuda Networks Inc (NYSE: CUDA):

  • [By WWW.THESTREET.COM]

    Turning Around Cybersecurity Through Activism
    As competition climbs and spending slows, security has attracted activists. (FEYE) (IMPV) (FTNT) (CHKP) Full story

  • [By Peter Graham]

    A long term performance chart shows Barracuda Networks peaking in 2015 before underperforming and moving back to break even levels while mid cap Fortinet Inc (NASDAQ: FTNT) and large cap Palo Alto Networks Inc (NYSE: PANW) also peaked in 2015, fell backand appear to be bouncing back:

  • [By Peter Graham]

    A long term performance chart shows Palo Alto Networks falling over the past two years, but still outperformingpotential peers in the space such as large cap Cisco Systems, Inc (NASDAQ: CSCO), mid capFortinet Inc (NASDAQ: FTNT) and small cap Barracuda Networks Inc (NYSE: CUDA):

  • [By Jim Robertson]

    On Wednesday, our Elite Opportunity Pronewsletter suggestedmid cap cyber security solutions stock Fortinet Inc (NASDAQ: FTNT) as a new long term idea because:

Top 10 Medical Stocks To Buy Right Now: American Woodmark Corporation(AMWD)


Advisors’ Opinion:

  • [By Lisa Levin]

    American Woodmark Corporation (NASDAQ: AMWD) shares shot up 29 percent to $128.15. American Woodmark reported purchase of RSI Home Products for $1.075 billion in enterprise value and posted upbeat quarterly earnings.

  • [By Lisa Levin]

    American Woodmark Corporation (NASDAQ: AMWD) shares shot up 25 percent to $124.80. American Woodmark reported purchase of RSI Home Products for $1.075 billion in enterprise value and posted upbeat quarterly earnings.

  • [By Lisa Levin]

    American Woodmark Corporation (NASDAQ: AMWD) was down, falling around 17 percent to $66.88 as the company reported weaker-than-expected quarterly earnings.

Top 10 Medical Stocks To Buy Right Now: ConAgra Foods, Inc.(CAG)

Advisors’ Opinion:

  • [By Trey Thoelcke]

    Conagra Brands Inc.’s (NYSE: CAG) fiscal second-quarter report is scheduled for first thing Thursday. Wall Street is looking for $0.52 in EPS and $2.06 billion in revenue. Shares closed trading at $37.76 on Friday, in a 52-week range of $32.16 to $41.68. The consensus price target is $40.43.

  • [By Lisa Levin] Related SOFO 12 Biggest Mid-Day Losers For Tuesday Earnings Scheduled For December 10, 2015
    Related WSCI 15 Biggest Mid-Day Losers For Wednesday Earnings Scheduled For June 21, 2016 Companies Reporting Before The Bell
    Rite Aid Corporation (NYSE: RAD) is projected to report its quarterly earnings at $0.04 per share on revenue of $8.23 billion.
    Conagra Brands Inc (NYSE: CAG) is estimated to report its quarterly earnings at $0.45 per share on revenue of $2.11 billion.
    Bioanalytical Systems, Inc. (NASDAQ: BASI) is expected to report earnings for the fourth quarter.


     

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Accenture Plc (NYSE: ACN) to report quarterly earnings at $1.3 per share on revenue of $8.34 billion before the opening bell. Accenture shares gained 0.41 percent to $127.00 in after-hours trading.
    Analysts expect Micron Technology, Inc. (NASDAQ: MU) to post quarterly earnings at $0.85 per share on revenue of $4.64 billion after the closing bell. Micron shares gained 0.88 percent to $26.29 in after-hours trading.
    Five Below Inc (NASDAQ: FIVE) reported better-than-expected earnings for its fourth quarter on Wednesday. Five Below shares climbed 8.23 percent to $41.27 in the after-hours trading session.
    Before the markets open, Conagra Brands Inc (NYSE: CAG) is projected to report its quarterly earnings at $0.44 per share on revenue of $1.98 billion. Conagra shares rose 1.73 percent to $41.18 in after-hours trading.
    PVH Corp (NYSE: PVH) posted upbeat earnings for its fourth quarter and issued a strong earnings forecast. PVH shares surged 7.15 percent to $97.35 in the after-hours trading session.


    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Laurie Kulikowski]

    Following 1) the recent sale of its Private Brands segment, 2) the announcement of the spin-off of Lamb Weston, 3) commentary around improving its margin structure in the Consumer segment, and 4) management’s recognition that the company has not raised its dividend in years, we think CAG is heading in the right direction. For income-oriented investors, note that CAG has a great deal of cash coming in from the Private Brands sale, and that management has stated its commitment to a strong dividend. As noted above, CAG is our best idea heading into new year. 

  • [By Lisa Levin]

    Breaking news

    Accenture Plc (NYSE: ACN) reported upbeat earnings for its second quarter.
    Five Below Inc (NASDAQ: FIVE) reported better-than-expected earnings for its fourth quarter on Wednesday.
    PVH Corp (NYSE: PVH) posted upbeat earnings for its fourth quarter and issued a strong earnings forecast.
    Conagra Brands Inc (NYSE: CAG) reported stronger-than-expected earnings for its third quarter.

  • [By Laurie Kulikowski]

    The debt-to-equity ratio is very high at 2.34 and currently higher than the industry average, implying increased risk associated with the management of debt levels within the company. Along with this, the company manages to maintain a quick ratio of 0.25, which clearly demonstrates the inability to cover short-term cash needs.


     

Top 10 Medical Stocks To Buy Right Now: Ternium S.A.(TX)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Shares of Ternium SA (NYSE:TX) jumped on Wednesday: up more than 10% by 2:30 p.m. EST. While the steelmaker reported weaker-than-expected earnings after the closing bell yesterday, it provided optimistic guidance and announced a compelling acquisition.

Top 10 Medical Stocks To Buy Right Now: PRA Group, Inc.(PRAA)


Advisors’ Opinion:

  • [By Lee Jackson]

    PRA Group Inc. (NASDAQ: PRAA) has been hit hard recently, and shareholders may be glad to know that a director took advantage of the sell-off and stepped in to buy shares. That board member bought 143,000 shares of the financial and business services company at prices that ranged from $34.40 to $34.89. The total for the buy was set at $5 million. The stock closed Friday at $32.90, in a52-week range of $21.93 to $42.70. The consensus price target is $40.60.

Top 10 Medical Stocks To Buy Right Now: Newmont Mining Corporation(NEM)


Advisors’ Opinion:

  • [By Joel Elconin]

    December gold futures have taken the SPDR Gold Trust (ETF) (NYSE: GLD) along for the ride; the ETF is trading higher by $1.74 at $124.48. That puts the ETF in the area it was the same day gold peaked during the Nov. 4 session, at $124.40, and well above the close from that day of $124.04. Also, Newmont Mining Corp (NYSE: NEM) shares were seen trading higher by $1.15 at $38.14 Monday. Earlier in the session, shares peaked at $38.91, just shy of its Oct. 3 high of $39.33.

  • [By Zacks]

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
     
    Kronos Worldwide Inc (NYSE: KRO): Free Stock Analysis Report
     
    Westlake Chemical Corporation (NYSE: WLK): Free Stock Analysis Report
     
    DAQO New Energy Corp. (NYSE: DQ): Free Stock Analysis Report
     
    Newmont Mining Corporation (NYSE: NEM): Free Stock Analysis Report
     
    To read this article on Zacks.com click here.
     
    Zacks Investment Research

  • [By James E. Brumley]

    When most people think of gold mining stocks, names like Barrick Gold Corporation (USA) (NYSE:ABX) and Newmont Mining Corp (NYSE:NEM) come to mind. And well they should. Newmont Mining and Barrick Gold are a pair of the industry’s biggest gold mining outfits, and each has successfully leveraged their size to turn reasonably consistent profits even in tough environments.

    At the end of the day though, Barrick Gold and Newmont Mining just don’t pack as much potential punch as the up-and-comers within the industry. It’s the small cap stocks and junior gold miners in this space that can pay off big-time for investors willing to get a little more speculative, and right now there’s not any junior gold mining name as compelling as an outfit called Taranis Resources Inc. (OTCMKTS:TNREF, TSX:TRO).


    Taranis develops mineral deposits into mine-ready projects. Its primary project right now — and it’s enough to keep the company plenty busy for the next several years — is the Thor property located near Trout Lake, British Columbia. NI 43-101 resource reports (indicated and inferred)suggest Thor contains 6.9 million ounces of silver, 35,000 ounces gold, 57 million pounds of lead, 79.4 million pounds of zinc and 3.3 Million pounds of copper (roughly a 14 million ounce silver equivalent (“AgEq”) deposit*) laying in wait in a way that lends itself to the establishment of a low-cost, open pit mining operation. That’s roughly $300 million worth of marketable metals, and the estimates have been steadily getting bigger as Tanaris does more survey work.


    And 2017 could be a real breakout year for Taranis, as a lot of the work that’s been done to date starts to mean something. It’s got big exploration plans for this year… this spring/summer to be exact.

    The Phase 1 program was completed in September of last year, setting the stage for a more defined and much bigger Phase 2 definition-drilling within the next several weeks. This Phase 2 defi

  • [By Ben Levisohn]

    Newmont Mining (NEM) soared to the top of the S&P 500 today after gold prices rose, lifting the entire gold mining sector.

    Agence France-Presse/Getty Images

    Newmont Mininggained 7.6% to $35.27 today, while the S&P 500 was little changed at 2,249.26. Front Month Comex Gold for January delivery gained 1.5% to $1156.40 today, while the VanEck Vectors Gold Miners ETF (GDX) climbed 7.8% to $21.82.

    Standpoint Research’s Ronnie Moas upgraded Newmont Mining to Buy from Hold today.

    Newmont Mining’s market capitalization rose to $18.7 billion today from $17.4 billion yesterday. It reported net income of $193 million on sales of $7.7 billion in 2015.

Top 10 Medical Stocks To Buy Right Now: Endologix, Inc.(ELGX)

Advisors’ Opinion:

  • [By Paul Ausick]

    Endologix Inc. (NASDAQ: ELGX) dropped about 9.3% on Wednesday to post a new 52-week low of $4.78 against a 52-week high of $14.50 and a Tuesday close of $5.27. Volume of about 6 million was more than 3 times the daily average of around 1.7 million. The company on Tuesday announced a temporary shipping hold on its best-selling heart device, saying there was a manufacturing issue.

  • [By Lisa Levin]

    Endologix, Inc. (NASDAQ: ELGX) shares dropped 23 percent to $7.59 as the company issued an update on Nellix PMA process. Endologix disclosed that the FDA has requested the company to provide a two-year patient follow-up data from the EVAS-FORWARD IDE study of Nellix System.

Top 10 Medical Stocks To Buy Right Now: Arlington Asset Investment Corp(AI)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    The first stock on our list today is Arlington Asset Management Corp. (NYSE: AI), which primarily acquires and holds mortgage-related assets. The company’s portfolio consists mostly of agency-backed mortgage-backed securities (MBS) and private-label, residential MBS. The best part is its massive 17.4% dividend yield.

Leave a Reply

Your email address will not be published. Required fields are marked *